SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Blumenfeld S Morry

(Last)

(First)

(Middle)

504 GRAND STREET

APARTMENT E-31

(Street)

NEW YORK

10002

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MAKO Surgical Corp. [ MAKO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2008

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/20/2008		P		10,000	A	$10	10,000	I	By Ziegler Meditech Equity Partners, L.P.⁽¹⁾
Common Stock	02/20/2008		P		5,000	A	$10	5,000	I	By Meditech Advisors LLC⁽²⁾
Common Stock	02/20/2008		C		488,509	A	⁽³⁾	498,509⁽³⁾	I	By Ziegler Meditech Equity Partners, L.P.⁽²⁾
Common Stock	02/20/2008		C		134,383	A	⁽³⁾	139,383⁽³⁾	I	By Meditech Advisors LLC⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series C Convertible Preferred Stock	⁽³⁾	02/20/2008		C			488,509	02/06/2007	⁽³⁾	Common Stock	488,509	$0.00	0	I	By Ziegler Meditech Equity Partners, L.P.⁽¹⁾
Series C Convertible Preferred Stock	⁽³⁾	02/20/2008		C			9,371	02/06/2007	⁽³⁾	Common Stock	9,371	$0.00	0	I	By Meditech Advisors LLC⁽²⁾
Series B Convertible Preferred Stock	⁽³⁾	02/20/2008		C			125,012	07/14/2005	⁽³⁾	Common Stock	125,012	$0.00	0	I	By Meditech Advisors LLC⁽²⁾

Explanation of Responses:

1. The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

2. The shares are owned by Meditech Advisors LLC, the partners of which are Eitan Machover, Samuel Cubac, Grosvenor LLC and Allandale Ltd. The reporting person and certain of his family members constitute the members of Grosvenor LLC. As such, the reporting may be deemed to be an indirect beneficial owner of these shares, but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.

3. The convertible preferred stock automatically converted into shares of MAKO Surgical Corp. common stock at the closing of the issuer's initial public offering and had no expiration date.

Remarks:

	/s/Menashe R. Frank, attorney in fact	02/22/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.